Compound Summary
DAPH
Compound Information
DAPH
Compound Name: | DAPH |
Compound CID: | 1697 |
Synonyms: | DAPH 4,5-dianilinophthalimide 145915-58-8 Cgp 52411 CGP52411 More... |
Iupac Name: | 5,6-dianilinoisoindole-1,3-dione |
InChI: | InChI=1S/C20H15N3O2/c24-19-15-11-17(21-13-7-3-1-4-8-13)18(12-16(15)20(25)23-19)22-14-9-5-2-6-10-14/h1-12,21-22H,(H,23,24,25) |
InChIKey: | AAALVYBICLMAMA-UHFFFAOYSA-N |
Canonical Smiles: | C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4 |
Isomeric Smiles: | C1=CC=C(C=C1)NC2=C(C=C3C(=C2)C(=O)NC3=O)NC4=CC=CC=C4 |
Molecular Weight: | 329.4 |
Molecular Formula: | C20H15N3O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
DAPH
Molecular Weight: | 329.4 |
Molecular Formula: | C20H15N3O2 |
Hydrogen Bond Donor Count: | 3 |
Hydrogen Bond Acceptor Count: | 4 |
Rotatable Bond Count: | 4 |
Heavy Atom Count: | 25 |
Complexity: | 453 |
Synonyms
DAPH
| DAPH | DAPH |
|---|---|
DAPH |
4,5-dianilinophthalimide |
145915-58-8 |
Cgp 52411 |
CGP52411 |
Cgp-52411 |
5,6-Bis(phenylamino)-1H-isoindole-1,3(2H)-dione |
5,6-Bis(phenylamino)isoindoline-1,3-dione |
DAPH-1 |
1H-Isoindole-1,3(2H)-dione, 5,6-bis(phenylamino)- |
UNII-Z13D008FZ2 |
CHEMBL268868 |
CHEBI:53110 |
Z13D008FZ2 |
5,6-dianilino-1h-isoindole-1,3(2h)-dione |
5,6-dianilinoisoindole-1,3-dione |
SCHEMBL11017 |
4,5-Bis(anilino)phthalimide |
4,5-bis-(anilino)phthalimide |
ZINC6094 |
DTXSID4040393 |
BCPP000288 |
HMS3260P13 |
HMS3413J22 |
HMS3677J22 |
BCP27630 |
VFA91558 |
Tox21_500236 |
BDBM50040929 |
DAPH, >=98% (HPLC), solid |
MFCD00236442 |
AKOS024457581 |
BCP9000511 |
CCG-221540 |
LP00236 |
SB66268 |
SDCCGSBI-0633694.P001 |
CGP52411;CGP-52411;DAPH |
NCGC00093700-01 |
NCGC00093700-02 |
NCGC00093700-03 |
NCGC00093700-04 |
NCGC00093700-05 |
NCGC00093700-07 |
NCGC00093700-08 |
NCGC00260921-01 |
5,6-Bis-phenylamino-isoindole-1,3-dione |
HY-103442 |
J587.895K |
B7384 |
CS-0027891 |
FT-0731235 |
J-008168 |
BRD-K13087974-001-01-7 |
Q27123966 |
Experimental Data
DAPH
| Species | Dose | Unit | Control(Avg days) | Treatment(Avg days) | Avg/Med Lifespan Change(%) | Control(Max days) | Treatment(Max days) | Max Lifespan Change(%) | Significant | Strain | Gender | PubMed | Avg/Med Lifespan Change tab |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33.000000000000000 | umol/L | 15.000000000000000 | S | N2 | 33683565 | Active | ||||||
| Caenorhabditis elegans | 13.000000000000000 | umol/L | 15.000000000000000 | S | N2 | 24134630 | Active |
Experimental Data Visualization
DAPH
Statistics Data
DAPH
| Species | Avg/Med Lifespan Change(%) | Max Lifespan Change(%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | 15.000000000000000 | 2 | 2 |
Statistics Data Visualization
DAPH
